Kurzweil: Life Is the Fast Lane

By John Russell

May 12, 2006 | Inventor and provocative futurist Ray Kurzweil’s opening keynote at the Bio-IT World Life Sciences Conference + Expo painted an expansive, optimistic vision of a world governed by exponentially growing information technologies that will inexorably transform what it means to be human, dramatically extend lifespan, and produce machines capable of modeling the human brain by 2029.

In his latest book, The Singularity Is Near: When Humans Transcend Biology, Kurzweil argues that biology has become an information science. When combined with advancing nanotechnology and computer technology, the new biology, he says, will unleash a new paradigm in life science. Smart nanobots will patrol the body repairing damage and regulating processes. Artificial blood cells might enable Olympic-like performance. Virtual reality systems will interface directly with the nervous system and be able to uncouple you from external sensory input if desired.

 Ray Kurzweil 
Ray Kurzweil
The power behind this progress, says Kurzweil, is the exponential rate of advance by information technologies, of which Moore’s familiar law for the doubling transistor performance roughly every 18 months is but one example. If his vision of the future is startling, he says, that’s only because life is perceived linearly. When plotted on a logarithmic scale, IT’s progress is a smooth straight line with interruptions such as wars, recessions, and pestilence — so prominent on a linear graph — dropping from sight.

“[The] 20th century was not a hundred years of progress at the year 2000 rate; it was picking up to that rate, it was about 20 years of progress at the year 2000 rate. [We’ll] make about 20,000 years of progress in the 21st, 1,000 times more than we did in the 20th century,” he said.

Kurzweil wowed his Bio-IT World audience of mostly technophiles in a mesmerizing, if largely unchallenged, performance for the accomplished technologist. A prolific inventor, he is perhaps best known for the Kurzweil music synthesizer, but other accomplishments include flat-bed scanning technology, a variety of speech-to-text and text-to-speech software, a knowledge-based medical reports system, and even a “cybernetic poet.”

Kurzweil views the sequencing of the genome as a watershed, turning biology into an explicit information science. Combined with other biotech technologies, we’re on the verge of being able to reprogram “23,000 software programs inside us called genes” using tools such as RNAi. This evolution, including our ability to manipulate the genome, follows an exponential growth rate, argues Kurzweil.

A core question is whether it will be possible to create a machine with truly human-level intelligence. Kurzweil certainly thinks so: “It would take thousands of trillions of bytes of information to characterize the state of a mature brain, and that’s a lot of complexity. But the complexity of the design of the brain is a billion times simpler, [perhaps] 30 million bytes, which is less than Microsoft Word,” Kurzweil said.

Signs of the Singularity
He forecasts that by 2013, supercomputers will reach processing speeds of 10*16 calculations per second, enough to emulate all the regions of the brain, and by 2029 will be able to model human intelligence. The toughest problem will be the software.

In Kurzweil’s vision, the blend of biology, nanotechnology, and computer technology — all racing along at exponential rates — will lead to well-understood and effective drugs and new drug delivery systems that promise to cure most disease and extend life. It’s a rosy view, but not without a few thorns.

All technologies have promises and peril, Kurzweil concedes, and sometimes they empower destructive individuals. More control of some scientific information may be needed. But suspension or denial of technological pursuit is not the answer, he says. That was the moral of Aldous Huxley’s A Brave New World. Abandoning technology drives it underground, where it’s actually much less stable, he contends.

Kurzweil eloquently states his case: “We are the species that goes beyond its limitations. We didn’t stay on the ground. We didn’t stay on the planet. We didn’t stay within the limitations of our biology. I believe within 10 or 15 years, we will add more than a year every year to the remaining years of life expectancy so as you go forward your remaining life expectancy will move away from you, so just hang in there another 10 or 15 years.”

White Papers & Special Reports

waters integrated
Integrated Software Approach to Streamline Method Development Workflow
Sponsored by Waters
Traditional chromatography method development evaluates numerous chromatographic variables that may include selection of the column, solvent, flow rate, etc. This application note demonstrates an integrated approach to capturing and storing separation related reports during chromatography method development.


HP white paper image
Extreme Storage Knowledge Center
Sponsored by HP

Visit HP’s Extreme Storage Knowledge Center to find informative, complimentary white papers, case studies, videos, product information and more.  Brief overview of topics:

  • The challenges of unstructured storage and how to manage both cost-effectively and efficiently
  • Company case studies of data storage challenges that translate across pharmaceutical and biotech companies today
  • Systems that manage vast amounts of data with simple deployment, unified management, and extreme scalability at an exceptionally low price per terabyte
  • Life sciences data management; viable solutions for small and large companies to manage growing storage demands
  • Take our virtual product tour and see our storage unit from inside out


Coupa white paper 92
10 Secrets to Recession-Proof Your Business
Sponsored by Coupa


Read this white paper to discover 10 strategies smart companies deploy to recession-proof their business.
Leaders generally face hard choices on how to mange a company during an economic downturn and
behave in one of three ways:
1) “The ostrich” - Preserve the status quo/hope for the best
2) “The bull in the china shop” - Blindly cut expenses across the board
3) “The fox” - Use the downturn to make your business more effective and position it for future growth

Learn how to behave “like a fox” and use a recession as a means to pounce on emerging trends.



Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms 

medidata podcastProtocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now 



More Podcasts

Job Openings

Manager, Scientific Computing & Programming
Lead SAIC-Frederick, Inc.’s Bioinformatics & Analysis Group in developing & maintaining informatics pipelines for generation/analysis of dense genotyping & next-generation sequencing data. Required:  MS or equiv.  5 yrs related experience.  Knowledge of programming/software development, high performance computing, bioinformatics, project management. Visit www.saic-frederick.com - #130019.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.